Abstract:Colorectal cancer (CRC) is one of the most common malignancies worldwide. The 5‐year survival rate of patients diagnosed with the early stages of the disease is markedly higher than that of patients in the advanced stages. Therefore, identifying novel biomarkers and drug targets for CRC is critical for clinical practice. Zinc finger protein 169 (ZNF169) is a crucial transcription factor, and its role in CRC remains to be explored. The present study aimed to investigate the clinical relevance, function and underlying mechanisms of ZNF169 in CRC growth and proliferation. The Cancer Genome Atlas (TCGA) database was utilized to analyze the clinical relevance of ZNF169 in patients with CRC. Immunohistochemical staining was performed on tissue samples from patients with CRC to detect the expression of ZNF169. The HCT‐116, HT‐29 and RKO cell lines were employed for in vitro experiments. The overexpression and knockdown of ZNF169 were achieved by transfecting the cells with lentivirus and small interfering RNAs, respectively. Cell Counting Kit‐8, colony formation and EdU staining assays were applied to investigate the function of ZNF169 in CRC cells. Dual luciferase activity and chromatin immunoprecipitation (ChIP)‐quantitative PCR (qPCR) assays were performed to identify the regulatory effects of ZNF169 on the ankyrin repeat and zinc‐finger domain‐containing 1 (ANKZF1; also known as ZNF744) gene. Reverse transcription‐quantitative PCR and western blot analysis were performed to measure mRNA and protein expression, respectively. The analysis of TCGA data revealed a positive correlation between ZNF169 and ANKZF1, with the overexpression of ANKZF1 being associated with a poor prognosis of patients with CRC. The experimental results demonstrated that ZNF169 was expression upregulated in CRC tissue compared with that in normal colon tissue. Gain‐of‐function and loss‐of‐function experiments revealed that ZNF169 enhanced the intensity of EdU staining, promoting the growth and proliferation of CRC cells. Furthermore, the overexpression of ZNF169 potentiated the transcriptional activity of the ANKZF1 gene, while the knockdown of ZNF169 produced the opposite results. ChIP‐qPCR confirmed the interaction between ZNF169 and the promoter sequence of ANKZF1. Rescue experiments revealed that ZNF169 accelerated CRC cell growth and proliferation through the upregulation of ANKZF1. Furthermore, there was a positive correlation identified between ZNF169 and ANKZF1, and upregulation of ANKZF1 expression was associated with the poor prognosis of patients with CRC. On the whole, the present study demonstrates that ZNF169 contributes to CRC malignancy by potentiating the expression of ANKZF1. Thus, the regulation of ZNF169 and/or ANKZF1 expression may represent a viable strategy for the treatment patients with CRC with a high expression of ZNF169.

Investigating the Prognostic and Oncogenic Roles of Membrane-Associated Ring-CH-Type Finger 9 in Colorectal Cancer

The Role of MARCH9 in Colorectal Cancer Progression

PIM3 Functions As Oncogenic Factor and Promotes the Tumor Growth and Metastasis in Colorectal Cancer

Ring Finger Protein 152 Inhibits Colorectal Cancer Cell Growth and is a Novel Prognostic Biomarker.

Comprehensive analysis of the clinical significance, immune infiltration, and biological role of MARCH ligases in HCC

Function and mechanism of MCM8 in the development and progression of colorectal cancer

Role of MARCH E3 ubiquitin ligases in cancer development

Abstract 4635: RNF208: A novel diagnostic and prognostic biomarker for colorectal cancer and key regulator of malignant behavior

MARCH1 as a novel immune-related prognostic biomarker that shapes an inflamed tumor microenvironment in lung adenocarcinoma

Role of MUC20 overexpression as a predictor of recurrence and poor outcome in colorectal cancer

Clinical value and potential association of Rab1A and FoxM1 aberrant expression in colorectal cancer

Overexpression of ZNF169 promotes the growth and proliferation of colorectal cancer cells via the upregulation of ANKZF1

Ring Finger Protein 215 is a Potential Prognostic Biomarker Involved in Immune Infiltration and Angiogenesis in Colorectal Cancer

Overexpression of Rab1B and MMP9 predicts poor survival and good response to chemotherapy in patients with colorectal cancer.

5‐FU inhibits migration and invasion of CRC cells through PI3K/AKT pathway regulated by MARCH1

MYH9 Promotes Growth and Metastasis via Activation of MAPK/AKT Signaling in Colorectal Cancer.

Ott_a_226520 3501..3510

CircXRN2 accelerates colorectal cancer progression through regulating miR-149-5p/MACC1 axis and EMT

Role of SMC1A overexpression as a predictor of poor prognosis in late stage colorectal cancer

Up-Regulated Expression of MCM 7 is a Poor Prognostic Factor in Colorectal Cancer

Systematic Pan-Cancer Analysis of RNF186 with Potential Implications in Progression and Prognosis in Human Cancer.